Aygen, Bilgehan, et al. “Immunosuppressive Therapy and the Risk of Hepatitis B Reactivation: Consensus Report”. Turkish Journal of Gastroenterology, vol. 29, no. 3, Jan. 2018, pp. 259-6, doi:10.5152/tjg.2018.18263.